Limitation of the therapeutic potential of DUSP4 through adaptive feedback partially mediated by DUSP5
Oncotarget · 05.11.2026 · 17 (1) · 502-520
DOI: 10.18632/oncotarget.28923 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncotarget, erschienen am 05.11.2026. Verfasst von Barbara Hopfgartner und 6 weiteren Autor:innen. Hauptthemen laut MEDLINE: Dual-Specificity Phosphatases, Mitogen-Activated Protein Kinase Phosphatases, Protein Tyrosine Phosphatases, Colorectal Neoplasms.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Zitieren
APA
Hopfgartner, B., Kriz, M., Alpar, D., Westermaier, Y., Hofmann, M. H., Neumüller, R. A., & Grosche, S. (2026). Limitation of the therapeutic potential of DUSP4 through adaptive feedback partially mediated by DUSP5. Oncotarget, 17(1), 502-520. https://doi.org/10.18632/oncotarget.28923
Vancouver
Hopfgartner B, Kriz M, Alpar D, Westermaier Y, Hofmann MH, Neumüller RA, et al. Limitation of the therapeutic potential of DUSP4 through adaptive feedback partially mediated by DUSP5. Oncotarget. 2026;17(1):502-520. doi:10.18632/oncotarget.28923
BibTeX
@article{Hopfgartner2026,
author = {Hopfgartner, Barbara and Kriz, Monika and Alpar, Donat and Westermaier, Yvonne and Hofmann, Marco H and Neumüller, Ralph A and Grosche, Sarah},
title = {Limitation of the therapeutic potential of DUSP4 through adaptive feedback partially mediated by DUSP5},
journal = {Oncotarget},
year = {2026},
volume = {17},
number = {1},
pages = {502--520},
doi = {10.18632/oncotarget.28923}
}
EUVIMED